Use of glucagon-like peptide-1 receptor agonists is associated with inadequate bowel preparation for colonoscopy in patients with diabetes. [PDF]
Ogawa O.
europepmc +1 more source
Glucagon-like-peptide-1 receptor agonists in the intensive care unit: practical implications for the intensivists. [PDF]
Bianchini L, Martins GAR, Myatra SN.
europepmc +1 more source
Beyond Weight Loss: Glucagon-Like Peptide-1 Receptor Agonists and Antipsychotic Adherence in Schizophrenia. [PDF]
López-Ibor I, Humphery H, Tafet G.
europepmc +1 more source
Glucagon-like Peptide-1 Receptor Agonists and Anaesthesia Considerations
Hemlata Kapoor, Dheeraj Kapoor
doaj +1 more source
Glucagon-Like Peptide 1 Receptor Agonists and Age-Related Macular Degeneration Incidence. [PDF]
Hallaj S +6 more
europepmc +1 more source
Glucagon-Like Peptide-1 Receptor Agonists: Considerations for Treating Preconception Obesity. [PDF]
Berube LT +4 more
europepmc +1 more source
Therapeutic Potential of Glucagon-like Peptide-1 Receptor Agonists in Respiratory Disorders. [PDF]
Russjan E, Zając D, Kaczyńska K.
europepmc +1 more source
Discontinuation of glucagon-like peptide-1 receptor agonists among US adults: A national survey. [PDF]
DiStefano MJ +5 more
europepmc +1 more source
Bowel Obstruction/Ileus Associated With the Use of Glucagon-Like Peptide-1 Receptor Agonists: A Nationwide Database Study. [PDF]
Matsuo Y +3 more
europepmc +1 more source
Neuropsychiatric Effects of Glucagon-Like Peptide-1 Receptor Agonists in Schizophrenia-Spectrum Disorders: A Systematic Review. [PDF]
Alsanosi ZY +10 more
europepmc +1 more source

